ASeq Newsletter

ASeq Newsletter

DetechGene!

Sep 18, 2025
∙ Paid

Information on DetechGene is quite limited. I could find one patent associated with the CEO and CTO related to a cartridge design for a LAMP assay which could be relevant.

But based on the information in the patent, and on the website I have a hard time determining exactly what makes DetechGene different from other players such as LumiraDx, Lucira, CoDx, Cue1 and other “at-home” molecular tests that gained some success during COVID but that have mostly failed to gain traction post COVID.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Nava Whiteford · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture